HEMLIBRA 105MG/0.7ML INJECTION

Yes, HEMLIBRA 105MG/0.7ML INJECTION can be self-administered at home after proper training and instructions from a healthcare professional. However, the decision to self-administer should be made in consultation with the healthcare team.

Yes, HEMLIBRA 105MG/0.7ML INJECTION is approved for use in pediatric patients with hemophilia A. The dosage and administration may vary depending on the age and weight of the child, and it should be prescribed and monitored by a healthcare professional.

HEMLIBRA 105MG/0.7ML INJECTION is specifically designed for the treatment of hemophilia A, which is caused by a deficiency of clotting factor VIII. It is not intended for other types of hemophilia, such as hemophilia B.

HEMLIBRA 105MG/0.7ML INJECTION is administered as a subcutaneous injection, generally, it is given once a week, every two weeks, or every four weeks, depending on the treatment plan determined by the healthcare provider. The frequency of the administration depends on your disease condition and other factors.

Before you start using HEMLIBRA 105MG/0.7ML INJECTION, talk to your doctor and carefully follow their instructions on when to use a bypassing agent and the dose and schedule you should use. It increases the ability of your blood to clot. Therefore, the dose of bypassing agent required may be lower than the dose you used before starting Hemlibra.

The provided information mentions interaction with other drugs. Always inform your doctor about all the medicines you are taking to avoid potential interactions.

This medicine is given as a shot under your skin (subcutaneous injection). It is usually injected into the upper outer arms, thighs, or stomach. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you rotate body areas. Do not inject into skin areas that are tender, red, bruised, hard, or not intact, or into areas with moles or scars. Use a new needle and syringe each time you inject your medicine.

Women should use an effective form of birth control to keep from getting pregnant. Tell your doctor right away if you think you have become pregnant. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.

EMICIZUMAB is the molecule used for making HEMLIBRA 105MG/0.7ML INJECTION.

Yes, HEMLIBRA 105MG/0.7ML INJECTION is indicated for Anti Cancer conditions.

HEMLIBRA 105MG/0.7ML INJECTION is prescribed for ailments such as Anti Cancer conditions.